Bactiguard wins another tender in Sweden
Bactiguard has won a tender for urinary catheters for the Västra Götaland region (VGR) in Sweden, which enables healthcare providers in both primary and secondary care and 49 municipalities in the region to purchase Bactiguards’ urinary catheters for infection prevention. The contract is valid for 2 years and can be extended for another 2 years.
“We are very pleased that VGR has also included infection prevention in their procured assortment, by adding our urinary catheter. Earlier this year, we have signed agreements with Stockholm County Council, Skåne region and the County Council in Värmland, which means that we now cover the majority of the country. The fact that the three largest county councils in Sweden have procured Bactiguard’s products is a quality stamp that we are very proud of”, says Nina Nilsson, SVP Sales and Marketing.
"Like the agreements for Stockholm and Skåne, the tender caters to both hospitalized patients and long-term catheterized patients, who visit primary or municipal healthcare facilities. This means that patients can continue using the Bactiguard catheters even when they have been released from hospital", Nina Nilsson explains.
The contract runs for two years from 1 April, 2018 and comprises BIP Foley Catheter Silicone. In accordance with Swedish tender law, the contracting authority will execute the formal contract once the appeal period has expired on 6 November, 2017.
Bactiguard is today procured through tenders in the following Swedish regions/county councils: Stockholm, Skåne, Värmland, Kronoberg, Blekinge, Kalmar, Halland and now also Västra Götaland.
For more information, please contact:
Nina Nilsson, SVP Sales and Marketing, Mobile: +46 70 214 87 49
Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission we develop and supply infection protection solutions which reduce the risk of healthcare associated infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large. The Bactiguard technology prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Through our licence partner CR Bard, urinary catheters with Bactiguard’s coating are market leading in the USA and Japan. Bactiguard’s own product portfolio of urinary catheters, endotracheal tubes and central venous catheters prevent some of the most common infections, which appear in the urinary tract, the blood stream and the respiratory tract.
Bactiguard is in a strong expansion phase in the European markets, China, India and the Middle East as well by establishing license agreements in new therapeutic areas. The company has about 60 employees around the world. Its headquarters and one of two production facilities are located in Stockholm, the other one in Malaysia. Bactiguard is listed on Nasdaq Stockholm.
Read more about how Bactiguard saves lives on www.bactiguard.com